Deliver innovative solutions faster with a consistent quality and compliance process
The pharmaceutical and biotech industries are adopting highly flexible and agile methodologies to accelerate their targeted therapeutic initiatives. Leveraging an extensive, connected regulatory and quality platform can help companies consistently approach quality, compliance, and regulatory activities. The Industry Solution Experience License to Cure for BioPharma addresses this new industry dynamic, while still providing the certainty and effectiveness of a proven governance model.
Dassault Systèmes is focused on helping pharmaceutical and biotech companies effectively adapt and manage their processes to meet today’s industry challenges. With the 3DEXPERIENCE platform and Industry Solution Experiences, Life Sciences companies can collaborate with the supply chainand regulatory agencies both pre-market and post-market through an online experience platform that helps ensure drugefficacy, safety, and quality. License to Cure for BioPharma enables companies to transition from a traditional productoriented model to the delivery of therapeutic solutions using a system that enables companies to be more reactive and responsive to quickly meet market needs.
- Leverage Unified Product Governance
- Deliver advanced therapeutic solutions to market faster